Skip to main content

A New Era of Highly Effective HIV Prevention: The Role of Primary Care. • Part Two, Antiretrovirals for HIV Prevention: PEP and PrEP in Clinical Practice

Posted in
Printer-friendly version

Ken Mayer, MD, a leading expert in HIV/AIDS research and practice will discussusing recent HIV prevention innovations in primary care settings. Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) will be discussed. Ken Mayer, MD is Medical Research Director and Co-Director of The Fenway Institute.  He is also Director of HIV Prevention Research and Attending Physician at Beth Israel Deaconess Hospital and Visiting Professor at Harvard Medical School.  

Timezone: 
EST
Location: 
United States